Metraipolis › archive › dc_e28b2c290256

An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN-Mediated Immune Evasion as a Therapeutic… — Europe PMC PMID:42122169

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42122169
DOI
10.3390/cancers18091373
License (as archived)
solo-consultazione
Archived
2026-11-03T06:49:27.645Z
SHA-256 of the archived text
cfc6f417168b50c495e58c9a40e258be03b5d25d9ff8d74469c898e88bbab7f5
Stable URL of this page
https://metraipolis.com/documento/dc_e28b2c290256

How to cite

An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN-Mediated Immune Evasion as a Therapeutic… — Europe PMC PMID:42122169 — Europe PMC (en), https://europepmc.org/article/MED/42122169 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e28b2c290256 (Metraipolis archive dc_e28b2c290256, sha256 cfc6f417168b50c495e58c9a40e258be03b5d25d9ff8d74469c898e88bbab7f5)
BibTeX
@misc{dce28b2c290256,
  title = {An Integrated Immunometabolic Signature Predicts Prognosis and Immunotherapy Response in ccRCC and Identifies UCN-Mediated Immune Evasion as a Therapeutic… — Europe PMC PMID:42122169},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42122169},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e28b2c290256; sha256 cfc6f417168b50c495e58c9a40e258be03b5d25d9ff8d74469c898e88bbab7f5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42122169. Agents can read the archived copy with the MCP tool read_document.